Stephen Basil Thomas
Director · Climb Bio, Inc.
IndividualSelling only5 10b5-1 trades
- 2025
- Sep 17, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Stephen Basil Thomas files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Aoife Brennan - $407K in CLYM purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $25K in CLYM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Stephen Basil Thomas?
Stephen Basil Thomas is a corporate insider, tracked as Director of Climb Bio, Inc. (CLYM). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Stephen Basil Thomas submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Stephen Basil Thomas been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($2.25M) across all tracked filings.
